永远不要浪费危机:FDA改革的过去,现在和未来
Patricia J Zettler1, Reshma Ramachandran2, Holly Fernandez Lynch3
1Ohio State University.
Journal of health politics, policy and law
|October 8, 2025
概括
美国食品和药物管理局 (FDA) 面临重大挑战,包括人员损失和政治干预,影响科学严谨性. 提出了一个原则和指标框架,以指导未来的FDA改革,重建公众的信任.
科学领域:
- 公共卫生政策 公共卫生政策
- 监管科学 监管科学
- 政府管理,政府管理.
背景情况:
- 美国食品和药物管理局 (FDA) 的任务是通过监管决策促进公共卫生,这需要科学专业知识和政治敏.
- 从历史上看,FDA已经进行了改革,以符合其使命,专注于证据,患者权利,创新,透明度和独立性.
- 政治行政部门的变化可能会影响FDA的优先事项,但第二届特朗普政府看到了影响机构运营的非凡转变.
研究的目的:
- 分析第二届特朗普政府期间FDA面临的重大变化和挑战.
- 突出这些变化对科学严谨性和公众信任带来的潜在风险.
- 为未来的有效性提出一个重建和改革FDA的框架.
主要方法:
- 在特定的管理过程中,FDA内部报告的变化的定性分析.
- 审查FDA的历史改革努力和声明的使命.
- 为未来的FDA改革制定一个概念框架.
主要成果:
- 特别的变化包括大量的专家人员和领导层的损失.
- 关于加速审查和批准的建议缺乏足够的证据.
- 报告指出,政治干预和忽视已建立的科学程序,破坏了科学完整性.
结论:
- 美国食品和药物管理局 (FDA) 的危机为重建和重新构想该机构提供了一个机会.
- 一套核心原则和相关指标可以指导政策选择和评估机构的行动.
- 这种框架可以帮助区分合理的政策变化和不合理的政策变化,促进科学严谨性和公众信任.
相关概念视频
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
01:26FDA Approved Drugs: Changes to Approved Drugs
214
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
214
01:03Drug Control Governance: Regulatory Bodies and Their Impact
457
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
457
01:28Drug Products: Biologics, Biosimilars and Interchangeables
208
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
208
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K